EUVIMEDEUVIMED entdecken
Crossref

Prevalent mesenchymal drift in aging and disease is reversed by partial reprogramming

Jinlong Y Lu, William B Tu, Ronghui Li, Mingxi Weng, Bhargav D Sanketi, Baolei Yuan, Pradeep Reddy, Concepcion Rodriguez Esteban, Juan Carlos Izpisua Belmonte

Cell · 2025-10 · 188 (21) · 5895-5911.e17

DOI: 10.1016/j.cell.2025.07.031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2025-10. Verfasst von Jinlong Y Lu und 8 weiteren Autor:innen. Beteiligte Einrichtung: San Diego Institute of Science, Altos Labs, San Diego, CA, USA. Hauptthemen laut MEDLINE: Aging, Cellular Reprogramming, Mesenchymal Stem Cells. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 108 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The loss of cellular and tissue identity is a hallmark of aging and numerous diseases, but the underlying mechanisms are not well understood. Our analysis of gene expression data from over 40 human tissues and 20 diseases reveals a pervasive upregulation of mesenchymal genes across multiple cell types, along with an altered composition of stromal cell populations, denoting a "mesenchymal drift" (MD). Increased MD correlates with disease progression, reduced patient survival, and an elevated mortality risk, whereas suppression of key MD transcription factors leads to epigenetic rejuvenation. Notably, Yamanaka factor-induced partial reprogramming can markedly reduce MD before dedifferentiation and gain of pluripotency, rejuvenating the aging transcriptome at the cellular and tissue levels. These findings provide mechanistic insight into the underlying beneficial effects of partial reprogramming and offer a framework for developing interventions to reverse age-related diseases using the partial reprogramming approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgingCellular ReprogrammingMesenchymal Stem CellsHumansAnimalsTranscription FactorsMiceEpigenesis, GeneticTranscriptome

Stichwörter der Autor:innen

Yamanaka factorsagingchronic kidney diseaseepithelial-mesenchymal transitionfibrosisheart failureidiopathic pulmonary fibrosismetabolic dysfunction-associated steatohepatitispartial reprogrammingrejuvenation

Substanzen

Transcription Factors

Autor:innen und Institutionen

  • San Diego Institute of Science, Altos Labs, San Diego, CA, USA.
  • San Diego Institute of Science, Altos Labs, San Diego, CA, USA; Salk Institute for Biological Studies, La Jolla, CA, USA.
  • San Diego Institute of Science, Altos Labs, San Diego, CA, USA; Salk Institute for Biological Studies, La Jolla, CA, USA. Electronic address: jcbelmonte@altoslabs.com.

Zitieren

APA

Lu, J. Y., Tu, W. B., Li, R., Weng, M., Sanketi, B. D., Yuan, B., Reddy, P., Rodriguez Esteban, C., & Izpisua Belmonte, J. C. (2025). Prevalent mesenchymal drift in aging and disease is reversed by partial reprogramming. Cell, 188(21), 5895-5911.e17. https://doi.org/10.1016/j.cell.2025.07.031

Vancouver

Lu JY, Tu WB, Li R, Weng M, Sanketi BD, Yuan B, et al. Prevalent mesenchymal drift in aging and disease is reversed by partial reprogramming. Cell. 2025;188(21):5895-5911.e17. doi:10.1016/j.cell.2025.07.031

BibTeX
@article{Lu2025,
  author = {Lu, Jinlong Y and Tu, William B and Li, Ronghui and Weng, Mingxi and Sanketi, Bhargav D and Yuan, Baolei and Reddy, Pradeep and Rodriguez Esteban, Concepcion and Izpisua Belmonte, Juan Carlos},
  title = {Prevalent mesenchymal drift in aging and disease is reversed by partial reprogramming},
  journal = {Cell},
  year = {2025},
  volume = {188},
  number = {21},
  pages = {5895--5911.e17},
  doi = {10.1016/j.cell.2025.07.031}
}
Kostenlos starten →